Press release
Forecast Indicates Nuclear Medicine Diagnostics Market Will Reach $13.77 Billion by 2030
Nuclear Medicine Diagnostics Market
Forecasted Expansion of the Nuclear Medicine Diagnostics Market Size
The nuclear medicine diagnostics market has experienced swift expansion in recent years. It is projected to grow from $7.88 billion in 2025 to $8.84 billion in 2026, representing a compound annual growth rate (CAGR) of 12.2%. This growth during the past period stems largely from the expanded utilization of radioactive tracers in diagnostic procedures, the rise in hospital-based nuclear medicine departments, increasing demand for functional imaging techniques, wider availability of technetium-based radiopharmaceuticals, and the surge in clinical research activities related to nuclear medicine.
Download a free sample of the nuclear medicine diagnostics market report:
https://thebusinessresearchcompany.com/sample_request?id=86114242&type=smp&name=Nuclear%20Medicine%20Diagnostics%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Nov_PR
Projected Growth Path and Opportunities Through 2030
Looking ahead, the market is expected to sustain robust growth, reaching $13.77 billion by 2030, with a CAGR of 11.7%. Factors contributing to this anticipated rise include growing investments in theranostic applications, greater adoption of precision oncology diagnostic tools, expansion of PET imaging infrastructure, a heightened focus on developing targeted radiopharmaceuticals, and stronger regulatory backing for nuclear diagnostic methods. Trends shaping this forecast involve increased use of PET-based diagnostic radiopharmaceuticals, escalating demand for personalized nuclear diagnostic solutions, closer integration between imaging and therapeutic approaches, growth in oncology-related nuclear medicine procedures, and an enhanced emphasis on radiotracers with shorter half-lives.
Prominent Players Driving the Nuclear Medicine Diagnostics Industry
The nuclear medicine diagnostics market features a range of influential companies shaping its progress, including Siemens AG, Bayer Aktiengesellschaft, Novartis AG, GE Healthcare Technologies Inc., Perkin Elmer Inc., Mallinckrodt Pharmaceuticals, Bracco Diagnostics Inc., Lantheus Holdings Inc., IBA Radiopharma Solutions, Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, Advanced Accelerator Applications, Telix Pharmaceuticals Limited, Nordion (Canada) Inc., NorthStar Medical Technologies LLC, SHINE Medical Technologies LLC, Navidea Biopharmaceuticals Inc., Cyclopharm Limited, Isologic Innovative Radiopharmaceuticals, Clarity Pharmaceuticals Limited, Actinium Pharmaceuticals Inc., Jubilant DraxImage Inc., PharmaLogic Holdings Corp, Institute of Isotopes Co Ltd., Theragnostics Ltd., and Eczacıbaşı-Monrol Nuclear Products Co.
View the full nuclear medicine diagnostics market report:
https://thebusinessresearchcompany.com/report/nuclear-medicine-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Nov_PR
Notable Acquisition Enhancing Capabilities in Radiopharmaceuticals
In March 2025, GE Healthcare Technologies, Inc., headquartered in the US, acquired Nihon Medi Physics Co., Ltd. (NMP), a Japan-based radiopharmaceutical manufacturer, for an undisclosed sum. This strategic purchase allows GE Healthcare to leverage NMP's expertise in the development and production of radioactive pharmaceuticals, boosting its capacity to deliver advanced molecular imaging agents targeting neurology, cardiology, and oncology. NMP specializes in supplying nuclear medicine diagnostics through its range of radiopharmaceutical products.
Advancements and Trends Shaping the Nuclear Medicine Diagnostics Landscape
Leading players in the nuclear medicine diagnostics field are focused on launching state-of-the-art medical technologies to remain competitive and improve patient outcomes. These innovative technologies aim to elevate the standard of care by enabling earlier disease detection and more precise treatment options. An example of this trend occurred in August 2023, when Gleneagles Hospital in Malaysia inaugurated a Nuclear Medicine Unit. This specialized center is equipped with the latest diagnostic technology and staffed by highly trained professionals to provide early diagnosis and treatment using nuclear medicine imaging techniques.
Segmentation Overview of the Global Nuclear Medicine Diagnostics Market
The nuclear medicine diagnostics market is divided into several key segments for detailed analysis. These include:
1) Type: SPECT Radiopharmaceuticals and PET Radiopharmaceuticals
2) Application Areas: Cardiology, Thyroid, Neurology, Oncology, and Other Applications
3) End-User Categories: Hospitals and Diagnostic Centers, and Research Institutes
Further breakdown of the subcategories includes:
- For SPECT Radiopharmaceuticals: Technetium-99m-Based, Iodine-123-Based, Thallium-201-Based, and Other SPECT Radiopharmaceuticals
- For PET Radiopharmaceuticals: Fluorine-18-Based, Carbon-11-Based, Gallium-68-Based, and Other PET Radiopharmaceuticals
This segmentation helps in understanding the market dynamics and identifying opportunities within specific application areas and product types.
Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Forecast Indicates Nuclear Medicine Diagnostics Market Will Reach $13.77 Billion by 2030 here
News-ID: 4683627 • Views: …
More Releases from The Business Research Company
The Non-PVC IV Bags Market is Projected to Grow to $3.8 Billion by 2030
The healthcare sector is witnessing a steady transformation with the growing preference for safer and more sustainable medical products. Among these, the non-PVC IV bags market is carving out a significant space, driven by advancements in medical technology and increasing awareness about the health risks associated with traditional materials. This overview explores the market's size, key drivers, main players, trends, and segmentation to provide a comprehensive understanding of its long-term…
Growth of the Maternal and Baby Grade Wipes Market Driven by the Use of Certifie …
The maternal and baby grade wipes market has witnessed substantial growth in recent times, driven by a combination of demographic shifts and evolving consumer preferences. As awareness around infant care and hygiene increases, the market is set to continue expanding significantly over the coming years. Below is a detailed breakdown of its current state, growth factors, major players, emerging trends, and key segments shaping this industry.
Maternal and Baby Grade Wipes…
Rising Breast Cancer Incidence Drives Growth and Demand in the Mammography Devic …
The mammography devices market has experienced significant growth recently and is poised for continued expansion in the coming years. This sector is evolving rapidly with technological advancements and increasing awareness about breast cancer screening, driving demand for more sophisticated imaging solutions. Let's explore the current market size, key growth drivers, prominent players, emerging trends, and segment analysis shaping this important healthcare industry.
Steady Growth in the Mammography Devices Market Size …
Drivers of the Lyophilization Equipment Market: Increasing Incidence of Chronic …
The lyophilization equipment market has been witnessing strong growth, driven by advancements in biopharmaceuticals, vaccines, and food preservation technologies. As industries increasingly adopt freeze-drying methods for sensitive products, the demand for efficient and innovative lyophilization systems is steadily rising. Let's explore the market's size, key drivers, major companies, trending innovations, and segment breakdowns shaping its future.
Projected Growth and Size of the Lyophilization Equipment Market
The lyophilization equipment market has…
More Releases for Medi
Medi-k "Bodran Foot Cream" Redefines Winter Foot Care
Image: https://www.globalnewslines.com/uploads/2025/10/9d1baf0cdded10bfa18b9398e3f26d59.jpg
Seoul, South Korea - With cold winds and thick winter socks causing cracked heels and rough skin, skincare brand Medi-k introduces a new solution: Bodran Foot Cream, a professional-grade moisturizer designed to restore softness and smoothness to dry, calloused feet.
Dermatologically tested, Bodran Foot Cream contains intensive hydrating ingredients that deeply penetrate rough heel and sole areas, leaving the skin noticeably softer. The formula is designed to deliver a soothing…
MEDI-K White Solution - Gentle Brightening for Delicate Areas
Image: https://www.globalnewslines.com/uploads/2025/07/7ddb11ca9baa14ab6b485543e4fd6d2f.jpg
As more consumers express concern over discoloration in delicate body areas, Korean body care brand MEDI-K is drawing attention with the launch of White Solution, a targeted product designed to gently improve uneven skin tone.
White Solution is formulated specifically for commonly darkened areas such as the bikini line (Y-zone), elbows, knees, and underarms. Unlike harsh whitening agents, this low-irritation brightening cream gradually helps improve skin tone with consistent use,…
Medi-k Launches 'Booster Magnesium Hot Spray'
Focused on Muscle Fatigue and Bruise Care with Topical Magnesium!
Image: https://www.globalnewslines.com/uploads/2025/06/18d367d6e1e28630963ec0dd84b8ef4d.jpg
In May 2025, Medi-k officially launched its Booster Magnesium Hot Spray (150ml), designed to help relieve muscle fatigue and improve circulation. This topical magnesium spray can be gently applied to the skin, making it convenient for daily use-both before and after workouts, as well as for managing bruises and muscle discomfort.
The spray is marketed as a cosmetic product and is…
[# Warning!] Medi Freeze Skin Tag Remover Report 2024 Exposed!
Skin tags are harmless, non-cancerous growths that can appear anywhere on the body, but they are often unsightly and can cause discomfort when rubbed against clothing or jewelry. If you're looking for an effective and safe solution to remove these unwanted growths, Medi Freeze Skin Tag Remover is an excellent choice.
⏭ Click Here Now to 🅾🆁🅳🅴🆁 🅽🅾🆆 👉👉 from the Official Website Today!
⏭ http://todaysdeals.kesug.com/get-medi-freeze-skin-tag-remover/
What is Medi Freeze Skin Tag…
MEDi, Japanese clinic management software, launches a new website
In October 6th 2023, MEDi, Japanese clinic management software, officially launches a new website interface with modern design, friendly user experience and many outstanding utilities.
With the desire to build a useful information channel for customers and partners, the new website of MEDi Japanese clinic management software, has been put into operation with the domain name: https://phanmemmedi.com/
The website of MEDi Japanese clinic management software is not only a platform to provide…
MEDi, Japanese clinic management software, launches treatment feature
Hanoi, on August 8, 2023, MEDi, a Japanese clinic management software, officially launches the treatment feature with outstanding improvements.
Established in 2019, MEDRiNG has become a reliable partner of clinics in Southeast Asia. In an effort to become the pioneer in the field of health-tech, MEDRiNG is constantly developing, providing innovative medical solutions to pave the future of healthcare.
With the aim of optimizing the treatment process for clinics, MEDRiNG officially launches…
